Annual report [Section 13 and 15(d), not S-K Item 405]

(Loss) Earnings per Share

v3.25.0.1
(Loss) Earnings per Share
 12 Months Ended
Dec. 31, 2024
Earnings Per Share [Abstract]  
(Loss) Earnings per Share (Loss) Earnings per Share
Basic and diluted (loss) earnings per share for the years ended December 31, 2024, 2023 and 2022, respectively consisted of the following (in thousands, except per share data):
Years Ended December 31,
2024 2023 2022
Numerator (Basic and Diluted):
Net (loss) income $ (12,362) $ (34,035) $ 104,225 
Change in value for stock settled consideration(1)
31 65 (37)
Adjusted net (loss) income $ (12,331) $ (33,970) $ 104,188 
Denominator:
Basic
Weighted average common shares issued and outstanding 38,695 38,674 39,751
Deduct: Unvested RSAs (2)
(17) (15) (12)
Add: Fully vested DSUs (3)
— — 154
Weighted average common shares outstanding 38,678 38,659 39,893
Basic (loss) earnings per common share $ (0.32) $ (0.88) $ 2.61 
Diluted
Weighted average common shares outstanding from above 38,678 38,659 39,893
Add: Dilutive effect of RSUs, RSAs & ESPP(4)
— 0 207
Add: Contingently issuable shares(1)(4)
— 0 86
Weighted average common shares outstanding 38,678 38,659 40,186
Diluted (loss) earnings per common share $ (0.32) $ (0.88) $ 2.59 
Antidilutive shares excluded from diluted earnings per common share(5)
962 1,593 1,084
(1)Relates to contingently issuable stock settled consideration.
(2)RSAs were issued and outstanding to the non-employee directors and have a one-year vesting term subject to service requirements. See Note 11 – “Stock-Based Compensation Plans” for additional information.
(3)Shares are included in weighted average common shares outstanding as the shares are fully vested but have not yet been delivered. See Note 11 – “Stock-Based Compensation Plans” for additional information.
(4)Shares related to the Company's RSUs, RSAs, ESPP, and contingently issuable shares were excluded from the weighted average common shares outstanding for the year ended December 31, 2024 because inclusion of such shares would be antidilutive in a period of loss.
(5)Primarily pertaining to RSU grants to the Company’s employees and independent contractors.